Yokoyama Akira, Kato Hoichi, Yokoyama Tetsuji, Tsujinaka Toshimasa, Muto Manabu, Omori Tai, Haneda Tatsumasa, Kumagai Yoshiya, Igaki Hiroyasu, Yokoyama Masako, Watanabe Hiroshi, Fukuda Haruhiko, Yoshimizu Haruko
National Institute on Alcoholism, Kurihama National Hospital, Yokosuka, Kanagawa 239-0841, Japan.
Carcinogenesis. 2002 Nov;23(11):1851-9. doi: 10.1093/carcin/23.11.1851.
The genetic polymorphisms of aldehyde dehydrogenase-2 (ALDH2), alcohol dehydrogenase-2 (ADH2), ADH3, and glutathione S-transferase M1 (GSTM1) influence the metabolism of alcohol and other carcinogens. The ALDH21/22 genotype, which encodes inactive ALDH2, and ADH21/21, which encodes the low-activity form of ADH2, enhance the risk for esophageal cancer in East Asian alcoholics. This case-control study of whether the enzyme-related vulnerability for esophageal cancer can be extended to a general population involved 234 Japanese men with esophageal squamous cell carcinoma and 634 cancer-free Japanese men who received annual health checkups. The GSTM1 genotype was not associated with the risk for this cancer. Light drinkers (1-8.9 units/week) with ALDH21/22 had an esophageal cancer risk 5.82 times that of light drinkers with ALDH21/21 (reference category), and their risk was similar to that of moderate drinkers (9-17.9 units/week) with ALDH21/21 (odds ratio = 5.58). The risk for moderate drinkers with ALDH21/22 (OR = 55.84) exceeded that for heavy drinkers (18+ units/week) with ALDH21/21 (OR = 10.38). Similar increased risks were observed for those with ADH21/21. A multiple logistic model including ALDH2, ADH2, and ADH3 genotypes showed that the ADH3 genotype does not significantly affect the risk for esophageal cancer. For individuals with both ALDH21/22 and ADH21/21, the risk of esophageal cancer was enhanced in a multiplicative fashion (OR = 30.12), whereas for those with either ALDH21/22 or ADH21/21 alone the ORs were 7.36 and 4.11. In comparison with the estimated population-attributable risks for preference for strong alcoholic beverages (30.7%), smoking (53.6%) and for lower intake of green and yellow vegetables (25.7%) and fruit (37.6%), an extraordinarily high proportion of the excessive risk for esophageal cancer in the Japanese males can be attributed to drinking (90.9%), particularly drinking by persons with inactive heterozygous ALDH2 (68.5%). Education regarding these risky conditions in connection with ALDH2 and ADH2 is vitally important in a new strategic approach aimed at preventing esophageal cancer in East Asians.
乙醛脱氢酶2(ALDH2)、乙醇脱氢酶2(ADH2)、ADH3以及谷胱甘肽S-转移酶M1(GSTM1)的基因多态性会影响酒精及其他致癌物的代谢。编码无活性ALDH2的ALDH21/22基因型以及编码低活性形式ADH2的ADH21/21基因型会增加东亚酗酒者患食管癌的风险。这项关于食管癌的酶相关易感性是否能扩展至普通人群的病例对照研究纳入了234名患有食管鳞状细胞癌的日本男性以及634名接受年度健康检查且无癌症的日本男性。GSTM1基因型与患这种癌症的风险无关。携带ALDH21/22的轻度饮酒者(每周1 - 8.9个饮酒单位)患食管癌的风险是携带ALDH21/21的轻度饮酒者(参照类别)的5.82倍,且他们的风险与携带ALDH21/21的中度饮酒者(每周9 - 17.9个饮酒单位)相似(比值比 = 5.58)。携带ALDH21/22的中度饮酒者的风险(比值比 = 55.84)超过了携带ALDH21/21的重度饮酒者(每周18个及以上饮酒单位)的风险(比值比 = 10.38)。携带ADH21/21的人也观察到了类似的风险增加情况。一个包含ALDH2、ADH2和ADH3基因型的多元逻辑模型显示,ADH3基因型对食管癌风险没有显著影响。对于同时携带ALDH21/22和ADH21/21的个体,患食管癌的风险以相乘的方式增加(比值比 = 30.12),而对于仅携带ALDH21/22或ADH21/21其中之一的个体,比值比分别为7.36和4.11。与偏好烈性酒精饮料(30.7%)、吸烟(53.6%)以及绿色和黄色蔬菜摄入量较低(25.7%)和水果摄入量较低(37.6%)的估计人群归因风险相比,日本男性食管癌额外风险中极高的比例可归因于饮酒(90.9%),尤其是携带无活性杂合ALDH2的人饮酒(68.5%)。在旨在预防东亚人患食管癌的新战略方法中,针对与ALDH2和ADH2相关的这些风险状况进行教育至关重要。